within Pharmacolibrary.Drugs.ATC.N;

model N05CD05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.44,
    Cl             = 1.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005666666666666667,
    Tlag           = 9.6
  );

  annotation(Documentation(
    info ="<html><body><p>Triazolam is a short-acting benzodiazepine used primarily for the treatment of insomnia. It is indicated for short-term management of sleep disorders and is not recommended for long-term use due to dependence and tolerance risks. Triazolam is still available in some countries but its use is restricted or discontinued in others due to safety concerns.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (male and female), age 19-38 years, after a single oral dose.</p><h4>References</h4><ol><li><p>Niemi, M, et al., &amp; Kivistö, KT (2003). Pharmacokinetic interactions with rifampicin : clinical relevance. <i>Clinical pharmacokinetics</i> 42(9) 819–850. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200342090-00003&quot;>10.2165/00003088-200342090-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12882588/&quot;>https://pubmed.ncbi.nlm.nih.gov/12882588</a></p></li><li><p>Karl, HW, et al., &amp; Mautz, D (1997). Pharmacokinetics of oral triazolam in children. <i>Journal of clinical psychopharmacology</i> 17(3) 169–172. DOI:<a href=&quot;https://doi.org/10.1097/00004714-199706000-00005&quot;>10.1097/00004714-199706000-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9169960/&quot;>https://pubmed.ncbi.nlm.nih.gov/9169960</a></p></li><li><p>Abernethy, DR, et al., &amp; Shader, RI (1984). The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam. <i>Clinical pharmacokinetics</i> 9(2) 177–183. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198409020-00005&quot;>10.2165/00003088-198409020-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6143633/&quot;>https://pubmed.ncbi.nlm.nih.gov/6143633</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CD05;
